Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

Novel screening method detects new N501T SARS-CoV-2 variant

Novel screening method detects new N501T SARS-CoV-2 variant

Accurate detection of D-dimer for pulmonary embolism among ER patients with suspected COVID-19

Accurate detection of D-dimer for pulmonary embolism among ER patients with suspected COVID-19

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Study determines the effect of mandatory facemask use in schools to manage the COVID-19 pandemic

Study determines the effect of mandatory facemask use in schools to manage the COVID-19 pandemic

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

COVID-19 incidence in K-12 schools in mask-required vs. mask-optional settings

COVID-19 incidence in K-12 schools in mask-required vs. mask-optional settings

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

Modeling study assesses the effectiveness facemasks before and after COVID-19 vaccination

How will mutations change the SARS-CoV-2 spike protein in the future?

How will mutations change the SARS-CoV-2 spike protein in the future?

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.